Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium
| Auteurs | Rup B, Pallardy M, Sikkema D, Albert T, Allez M, Broet P, Carini C, Creeke P, Davidson J, De Vries N, Finco D, Fogdell-Hahn A, Havrdova E, Hincelin-Mery A, Holland MC, Jensen PEH, Jury EC, Kirby H, Kramer D, Lacroix-Desmazes S, Legrand J, Maggi E, Maillere B, Mariette X, Mauri C, Mikol V, Mulleman D, Oldenburg J, Paintaud G, Pedersen CR, Ruperto N, Seitz R, Spindeldreher S, Deisenhammer F |
| Revue | |
| Institut | iBiTec-S |
| Année | 2 015 |